Peringatan Keamanan

Oral, rat LD50: 109±4 mg/kg

Levallorphan

DB00504

small molecule approved

Deskripsi

An opioid antagonist with properties similar to those of naloxone; in addition it also possesses some agonist properties. It should be used cautiously; levallorphan reverses severe opioid-induced respiratory depression but may exacerbate respiratory depression such as that induced by alcohol or other non-opioid central depressants. (From Martindale, The Extra Pharmacopoeia, 30th ed, p683)

Struktur Molekul 2D

Berat 283.4079
Wujud solid

Peta Jejaring Molekuler
Legenda: ObatTargetGenEnzim(Panah → menunjukkan arah efek / relasi)TransporterCarrier

Profil Farmakokinetik

Waktu Paruh (Half-Life) 1 hour
Volume Distribusi -
Klirens (Clearance) -

Absorpsi

Rapidly absorbed.

Metabolisme

Hepatic.

Rute Eliminasi

Data eliminasi belum tersedia.

Interaksi Obat

54 Data
Methylnaltrexone Levallorphan may increase the opioid antagonism activities of Methylnaltrexone.
Naloxegol Levallorphan may increase the opioid antagonism activities of Naloxegol.
Tramadol The therapeutic efficacy of Tramadol can be decreased when used in combination with Levallorphan.
Morphine The therapeutic efficacy of Morphine can be decreased when used in combination with Levallorphan.
Codeine The therapeutic efficacy of Codeine can be decreased when used in combination with Levallorphan.
Hydromorphone The therapeutic efficacy of Hydromorphone can be decreased when used in combination with Levallorphan.
Methadone The therapeutic efficacy of Methadone can be decreased when used in combination with Levallorphan.
Meperidine The therapeutic efficacy of Meperidine can be decreased when used in combination with Levallorphan.
Oxycodone The therapeutic efficacy of Oxycodone can be decreased when used in combination with Levallorphan.
Butorphanol The therapeutic efficacy of Butorphanol can be decreased when used in combination with Levallorphan.
Dextropropoxyphene The therapeutic efficacy of Dextropropoxyphene can be decreased when used in combination with Levallorphan.
Pentazocine The therapeutic efficacy of Pentazocine can be decreased when used in combination with Levallorphan.
Naltrexone The therapeutic efficacy of Naltrexone can be decreased when used in combination with Levallorphan.
Sufentanil The therapeutic efficacy of Sufentanil can be decreased when used in combination with Levallorphan.
Alfentanil The therapeutic efficacy of Alfentanil can be decreased when used in combination with Levallorphan.
Fentanyl The therapeutic efficacy of Fentanyl can be decreased when used in combination with Levallorphan.
Nalbuphine The therapeutic efficacy of Nalbuphine can be decreased when used in combination with Levallorphan.
Levorphanol The therapeutic efficacy of Levorphanol can be decreased when used in combination with Levallorphan.
Remifentanil The therapeutic efficacy of Remifentanil can be decreased when used in combination with Levallorphan.
Buprenorphine The therapeutic efficacy of Buprenorphine can be decreased when used in combination with Levallorphan.
Hydrocodone The therapeutic efficacy of Hydrocodone can be decreased when used in combination with Levallorphan.
Diphenoxylate The therapeutic efficacy of Diphenoxylate can be decreased when used in combination with Levallorphan.
Oxymorphone The therapeutic efficacy of Oxymorphone can be decreased when used in combination with Levallorphan.
Dezocine The therapeutic efficacy of Dezocine can be decreased when used in combination with Levallorphan.
Levacetylmethadol The therapeutic efficacy of Levacetylmethadol can be decreased when used in combination with Levallorphan.
Methadyl acetate The therapeutic efficacy of Methadyl acetate can be decreased when used in combination with Levallorphan.
Dihydroetorphine The therapeutic efficacy of Dihydroetorphine can be decreased when used in combination with Levallorphan.
Diamorphine The therapeutic efficacy of Diamorphine can be decreased when used in combination with Levallorphan.
Bezitramide The therapeutic efficacy of Bezitramide can be decreased when used in combination with Levallorphan.
Ethylmorphine The therapeutic efficacy of Ethylmorphine can be decreased when used in combination with Levallorphan.
Etorphine The therapeutic efficacy of Etorphine can be decreased when used in combination with Levallorphan.
Dextromoramide The therapeutic efficacy of Dextromoramide can be decreased when used in combination with Levallorphan.
Desomorphine The therapeutic efficacy of Desomorphine can be decreased when used in combination with Levallorphan.
Carfentanil The therapeutic efficacy of Carfentanil can be decreased when used in combination with Levallorphan.
Dihydrocodeine The therapeutic efficacy of Dihydrocodeine can be decreased when used in combination with Levallorphan.
Alphacetylmethadol The therapeutic efficacy of Alphacetylmethadol can be decreased when used in combination with Levallorphan.
Dihydromorphine The therapeutic efficacy of Dihydromorphine can be decreased when used in combination with Levallorphan.
Tapentadol The therapeutic efficacy of Tapentadol can be decreased when used in combination with Levallorphan.
Ketobemidone The therapeutic efficacy of Ketobemidone can be decreased when used in combination with Levallorphan.
DPDPE The therapeutic efficacy of DPDPE can be decreased when used in combination with Levallorphan.
Lofentanil The therapeutic efficacy of Lofentanil can be decreased when used in combination with Levallorphan.
Eluxadoline The therapeutic efficacy of Eluxadoline can be decreased when used in combination with Levallorphan.
Opium The therapeutic efficacy of Opium can be decreased when used in combination with Levallorphan.
Normethadone The therapeutic efficacy of Normethadone can be decreased when used in combination with Levallorphan.
Piritramide The therapeutic efficacy of Piritramide can be decreased when used in combination with Levallorphan.
Alphaprodine The therapeutic efficacy of Alphaprodine can be decreased when used in combination with Levallorphan.
Nicomorphine The therapeutic efficacy of Nicomorphine can be decreased when used in combination with Levallorphan.
Meptazinol The therapeutic efficacy of Meptazinol can be decreased when used in combination with Levallorphan.
Phenoperidine The therapeutic efficacy of Phenoperidine can be decreased when used in combination with Levallorphan.
Phenazocine The therapeutic efficacy of Phenazocine can be decreased when used in combination with Levallorphan.
Tilidine The therapeutic efficacy of Tilidine can be decreased when used in combination with Levallorphan.
Carfentanil, C-11 The therapeutic efficacy of Carfentanil, C-11 can be decreased when used in combination with Levallorphan.
Benzhydrocodone The therapeutic efficacy of Benzhydrocodone can be decreased when used in combination with Levallorphan.
Oliceridine The therapeutic efficacy of Oliceridine can be decreased when used in combination with Levallorphan.

Target Protein

Neuronal acetylcholine receptor subunit alpha-2 CHRNA2
Mu-type opioid receptor OPRM1

Referensi & Sumber

Belum ada data referensi/link/attachment untuk obat ini pada database. Jalankan import DrugBank untuk mengisi field referensi.

Contoh Produk & Brand

Produk: 0 • International brands: 1
International Brands
  • Lorfan — Takeda

Sekuens Gen/Protein (FASTA)

Sekuens dimuat saat dibutuhkan agar halaman tetap ringan.
© 2025 Digital Pharmacy Research - Universitas Esa Unggul